Company launches suite of multi-omics tools to e
Author: Michael
Reverse merger spawns new Nasdaq biotech develop
Targeting ‘remnant cholesterol,’ company’s
Dominika Wilczok reports on this year’s Summit
Dominika Wilczok reports on the latest aging res
A new aging atlas offering scientists a detailed
Buck scientists uncover new signaling pathway th
Star Trek star boldly joins Biotech Explorers lo
New study finds intensive lifestyle changes, inc
Company’s new Niagen+ IV treatment claimed to